Skip to main content

Published locations for FDA approves pembrolizumab for sorafenib-intolerant HCC patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves pembrolizumab for sorafenib-intolerant HCC patients

User login

  • Reset your password
  • /content/fda-approves-pembrolizumab-sorafenib-intolerant-hcc-patients
  • /gihepnews/article/184307/gastroenterology/fda-approves-pembrolizumab-sorafenib-intolerant-hcc
  • /oncologypractice/article/184307/gastroenterology/fda-approves-pembrolizumab-sorafenib-intolerant-hcc
  • /hematology-oncology/article/184307/gastroenterology/fda-approves-pembrolizumab-sorafenib-intolerant